HSPB1 and prostate carcinoma: Recent research has found that erastin could enhance the expression of HSPB1 mRNA and protein and that the HSF1‐HSPB1 pathway could negatively regulate erastin‐induced ferroptosis in human cervical cancer cells, osteosarcoma cells and prostate cancer cells 65.